ArticleJournal of the American Chemical Society2026
Controlled Precursor Differentiation Enables Palladium-Catalyzed Divergent Carbonylation of Cyclobutenols.
Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Controlling reaction selectivity is a central challenge in synthetic chemistry, particularly when multiple competing reactivity modes coexist within a single substrate. Existing strategies generally rely either on selectivity control during substrate activation or on downstream divergence from a common intermediate. However, these paradigms are less effective when distinct precursor states can independently evolve into distinct reaction manifolds. Herein, we introduce precursor differentiation as a distinct strategy for achieving divergent carbonylation. Through condition-controlled modulation of substrate evolution, a common cyclobutenol substrate can be selectively diverted into two distinct reactive precursors prior to catalytic engagement, thereby enabling access to two different carbonylation pathways. Under palladium catalysis, this strategy enables the highly selective synthesis of either hydroxyl-retained cyclobutanecarboxamides or cyclobutenamides from the same cyclobutenol platform. The method exhibits broad substrate scope (99 examples), consistently high selectivity (>20:1), and compatibility with pharmaceuticals and biologically relevant molecules. Furthermore, the resulting cyclobutenamide products serve as versatile platform intermediates for the selective synthesis of structurally distinct 3-azabicyclo[3.2.0]heptane and 3-azabicyclo[3.1.1]heptane frameworks. Mechanistic studies support a condition-controlled precursor differentiation process prior to carbonylation, providing a conceptual basis for achieving divergent carbonylation through selective control of precursor evolution.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.